Cervical Ripening Double Balloon Catheter for Cervical Ripening
(CRDB RCT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the Cervical Ripening Double Balloon (CRDB) catheter, a special type of thin tube, is more effective than usual osmotic dilators for preparing the cervix before a dilation and evacuation (D&E) procedure. Although the CRDB catheter is already approved for assisting with labor at full term, this study tests its use in the second trimester. Women between 19 and 23 weeks pregnant, planning a D&E, and residing in Connecticut may qualify for this trial.
As an unphased study, this trial allows participants to contribute to important research that could enhance medical procedures.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you have a contraindication (a medical reason not to use) to medications used during standard cervical preparation, you may not be eligible to participate.
What prior data suggests that the Cervical Ripening Double Balloon (CRDB) Catheter is safe for cervical dilation?
Research has shown that the Cervical Ripening Double Balloon (CRDB) Catheter is generally safe for use. Studies indicate that this catheter carries a low risk of complications during labor induction. The primary concern is a small chance of infection, though this is uncommon. The FDA has approved the CRDB Catheter to help open the cervix (the lower part of the uterus) before childbirth at full term. This approval suggests it is well-tolerated for similar uses.12345
Why are researchers excited about this trial?
The Cervical Ripening Double Balloon (CRDB) Catheter is unique because it offers a mechanical method to help prepare the cervix for childbirth. Unlike current options like osmotic dilators, which absorb moisture to expand and dilate the cervix gradually, the CRDB Catheter uses a dual-balloon system to apply direct pressure, potentially speeding up the ripening process. Researchers are excited about this treatment as it may provide a more controlled and faster approach to cervical ripening, potentially leading to a smoother labor process.
What evidence suggests that the Cervical Ripening Double Balloon Catheter is effective for cervical dilation?
Studies have shown that the double-balloon catheter, which participants in this trial may receive, effectively prepares the cervix for labor by softening and opening it. In one study, 91% of women achieved successful vaginal births using this method, with low risks of infection and bleeding. Although it hasn't been proven superior to other methods, many doctors find it effective. Typically used at the end of pregnancy, the double-balloon catheter works similarly if used earlier, suggesting it might also help open the cervix in the second trimester. Another treatment option in this trial is the use of osmotic dilators, serving as an active comparator.16789
Who Is on the Research Team?
Tessa Madden, MD
Principal Investigator
Yale University
Are You a Good Fit for This Trial?
This trial is for patients needing cervical preparation before a dilation and evacuation (D&E) procedure. Participants should require the procedure, be willing to stay overnight in the hospital, and have no contraindications to using CRDB catheters or osmotic dilators.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Cervical Preparation
Participants undergo cervical preparation using either a CRDB catheter or osmotic dilators overnight
Dilation and Evacuation (D&E)
The cervical dilating device is removed, and the D&E procedure is performed
Follow-up
Participants are monitored for safety and effectiveness after the D&E procedure
What Are the Treatments Tested in This Trial?
Interventions
- Cervical Ripening Double Balloon (CRDB) Catheter
- Osmotic Dilators
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor